SCHEMBL278161

SCHEMBL278161

Brn1cnc2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.54
HTT P42858 4/20 0.52
SMN1; SMN2 Q16637 3/20 0.48
LMNA P02545 2/20 0.48
STAT6 P42226 1/20 0.48
CYP11B1 P15538 3/20 0.47
CYP11B2 P19099 3/20 0.47
POLB P06746 1/20 0.47
TNF P01375 1/20 0.47
FGFR1 P11362 1/20 0.46
MEN1 O00255 1/20 0.44
HPGD P15428 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MAPK1 P28482 1/20 0.43
EGLN3 Q9H6Z9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30744769 0.98 TDP1 (0.52) TDP1HTTSMN1; SMN2LMNASTAT6
Decane SCHEMBL9491454 0.87 ASAH1 (0.54) TDP1HTTSMN1; SMN2LMNACYP11B1
SCHEMBL7196401 0.75 TDP1 (0.58) TDP1HTTSMN1; SMN2LMNASTAT6
SCHEMBL3417306 0.74 HTT (0.73) TDP1HTTPOLBFGFR1
SCHEMBL23877945 0.74 CYP11B1 (0.45) HTTCYP11B1CYP11B2
SCHEMBL22617807 0.74 MAPT (0.33) TDP1FGFR1HSD17B10
SCHEMBL2489876 0.73 TDP1 (0.56) TDP1HTTSMN1; SMN2LMNASTAT6
SCHEMBL7555734 0.73 HTT (0.53) TDP1HTTSMN1; SMN2LMNASTAT6
SCHEMBL5399 0.71 TDP1 (0.59) TDP1HTTSMN1; SMN2LMNACYP11B1
SCHEMBL277760 0.71 TDP1 (0.54) TDP1HTTSMN1; SMN2LMNASTAT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1843 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119059958-A Method for aryl debromination acylation of bromobenzazepine compounds 上海沃凯生物技术有限公司 2024-12-03 CN claimed
CN-118834244-A N-heterocyclic carbene-Schiff base type Csp2^Nsp2Bidentate ring palladium complex and synthetic method and application thereof 常州大学 2024-10-25 CN claimed
CN-118666659-A Benzoin based on benzimidazole bromide catalysis and synthesis method of benzoin derivative 合肥大学 2024-09-20 CN claimed
CN-116675609-A Strong alkaline ionic liquid and preparation method and application thereof 沈阳化工大学 2023-09-01 CN claimed
CN-111635437-B Palladium complex containing ortho-carborane benzimidazole structure, and preparation method and application thereof 上海应用技术大学 2023-04-28 CN claimed
US-20230123029-A1 ZIF NANOPARTICLE CONTAINING TRI-LIGANDS, THE METHOD OF MANUFACTURING THE SAME, MIXED MATRIX MEMBRANE COMPRISING THE SAME AND METHOD OF SEPARATING GAS USING THE MEMBRANE SOGANG UNIVERSITY RESEARCH & BUSINESS DEVELOPMENT FOUNDATION (KR) 2023-04-20 US claimed
CN-110117299-B Rhodium complex containing ortho-carbon boron alkyl benzimidazole structure and preparation and application thereof 上海应用技术大学 2021-05-11 CN claimed
CN-110105403-B Iridium complex containing carboranyl benzimidazole structure, preparation method and application thereof 上海应用技术大学 2021-02-26 CN claimed
CN-110016061-B Ruthenium complex containing carboranyl benzimidazole structure, preparation method and application thereof 上海应用技术大学 2021-02-26 CN claimed
CN-111635437-A Palladium complex containing ortho-position carborane-based benzimidazole structure and preparation method and application thereof 上海应用技术大学 2020-09-08 CN claimed
CN-104892523-B A kind of benzimidazole bromine salt compounds and its synthesis and be used as acceptor molecule bore hole colorimetric identification CN‑Application 西北师范大学 2017-09-22 CN claimed
CN-105457029-A Application of promoting expression of I-type interferon by inhibiting activity of casein kinase 2 INST PASTEUR OF SHANGHAI CHINESE ACAD OF SCIENCES 2016-04-06 CN claimed
CN-105315603-A Flame-retardant thermoplastic elastomer composition Jiaxing boer plastic co ltd 2016-02-10 CN claimed
EP-2021330-A2 BENZIMIDAZOLE MODULATORS OF VR1 Janssen Pharmaceutica, N.V. (BE) 2009-02-11 EP claimed
WO-2007130780-A2 BENZIMIDAZOLE MODULATORS OF VR1 JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-15 WO claimed
US-20030027842-A1 Halogenobenzimidazoles ASSMANN LUTZ (DE) 2003-02-06 US claimed
EP-0844998-A1 HALOBENZIMIDAZOLES AND THEIR USE AS MICROBICIDES BAYER AG (DE) 1998-06-03 EP claimed
WO-1997006171-A1 HALOBENZIMIDAZOLES AND THEIR USE AS MICROBICIDES BAYER AKTIENGESELLSCHAFT (DE) 1997-02-20 WO claimed
US-4258129-A IMPROVE GREEN SHELF LIFE FUJI PHOTO FILM CO., LTD. (JP) 1981-03-24 US claimed
US-4002479-A ORGANIC SILVER SALT, SILVER HALIDE, AND A REDUCING AGENT FUJI PHOTO FILM CO., LTD. (JA) 1977-01-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030027842-A1 Halogenobenzimidazoles MSR1, MRPS23, CBR1 TDP1 3173/4885HTT 4289/4885SMN1; SMN2 4773/4885
US-20230123029-A1 ZIF NANOPARTICLE CONTAINING TRI-LIGANDS, THE METHOD OF MANUFACTURING THE SAME, MIXED MATRIX MEMBRANE COMPRISING THE SAME AND METHOD OF SEPARATING GAS USING THE MEMBRANE IKZF3, TIMCC, EPCAM TDP1 4847/4885HTT 4179/4885SMN1; SMN2 4200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.